Aurora Cannabis (ACB) Fundamental Analysis: Revenue, Earnings & Valuation

5.75 / 10

Netural

Fundamental rating is neutral. PB at 0.46 (group 1) and PCF 13.84 (group 4) are strong, while GPM and NPM sit in low quartiles. CFOA, GMAR, GPOA and EV/EBIT show moderate to good quality, yielding a mixed but acceptable financial profile.

Analysis Checks(7/10)

PB

Value0.46

Score3/3

Weight11.14%

1M Return12.10%

PCF

Value13.84

Score3/3

Weight13.18%

1M Return12.38%

EV/EBIT

Value-6.45

Score2/3

Weight10.35%

1M Return10.47%

GPM

Value0.90

Score1/3

Weight7.98%

1M Return8.98%

GMAR

Value0.90

Score0/3

Weight4.72%

1M Return5.46%

PB-ROE

Value-0.58

Score3/3

Weight11.75%

1M Return12.66%

Income tax / Total profit (%)

Value6.50

Score2/3

Weight6.91%

1M Return7.38%

CFOA

Value0.03

Score2/3

Weight9.91%

1M Return9.34%

GPOA

Value0.09

Score3/3

Weight16.49%

1M Return15.11%

NPM

Value0.36

Score1/3

Weight7.58%

1M Return8.55%

Is ACB undervalued or overvalued?

ACB scores 5.75/10 on fundamentals and holds a Fair valuation at present. Backed by its -12.72% ROE, -24.69% net margin, -2.81 P/E ratio, 0.45 P/B ratio, and -5728.33% earnings growth, these metrics solidify its Netural investment rating.